Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Summaries of Product Characteristics 151 - 180 of 221
<  Previous 30    |  1  2  3  4  5  6  7  8  |  Next 30   >
Package leaflet	Status for supply	Name of the medicinal product
PL	Resepti	Formoterol Stada 12 mikrog inhalaatiojauhe, kapseli, kova SPC 2021-12-13
		European Medicines Agency's website: Forsteo - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Fortacin (ent. Lidocaine/Prilocaine Plethora) - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Forxiga - EMA: EPAR PI Finnish Swedish
PL	Resepti	Fosaprepitant Accord 150 mg infuusiokuiva-aine, liuosta varten SPC 2023-03-13
PL	Resepti	Fosastad 70 mg - 2800 IU, 70 mg - 5600 IU tabletti SPC 2023-01-16
		European Medicines Agency's website: Fosavance - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Foscan - EMA: EPAR PI Finnish Swedish
PL	Resepti	Foscarnet Tillomed 24 mg-ml infuusioneste, liuos SPC 2022-06-30
PL	Resepti	Fosfomycin Infectopharm 40 mg-ml infuusiokuiva-aine, liuosta varten SPC 2022-02-02
PL	Resepti	Fosrenol 1000 mg jauhe SPC 2023-10-16
PL	Resepti	Fosrenol 1000 mg purutabletti SPC 2023-10-16
PL	Resepti	Fosrenol 250 mg purutabletti SPC 2023-10-16
PL	Resepti	Fosrenol 500 mg purutabletti SPC 2023-10-16
PL	Resepti	Fosrenol 750 mg jauhe SPC 2023-10-16
PL	Resepti	Fosrenol 750 mg purutabletti SPC 2023-10-16
PL	Resepti	Fostimon 150 IU-ml injektiokuiva-aine ja liuotin, liuosta varten SPC 2023-08-07
PL	Resepti	Fostimon 75 IU-ml injektiokuiva-aine ja liuotin, liuosta varten SPC 2023-08-07
PL	Resepti	Fostimon Set 225 IU, 300 IU injektiokuiva-aine ja liuotin, liuosta varten SPC 2023-08-07
PL	Resepti	Fostimon Set 75 IU, 150 IU injektiokuiva-aine ja liuotin, liuosta varten SPC 2023-08-03
PL	Resepti	Fotil forte silmätipat, liuos, kerta-annospakkaus SPC 2021-10-18
PL	Resepti	Fotil ja Fotil Forte silmätipat, liuos SPC 2021-10-18
PL	Resepti	Fotil ja Fotil Forte silmätipat, liuos SPC 2021-10-18
		European Medicines Agency's website: Fotivda - EMA: EPAR PI Finnish Swedish
PL	Resepti	Fragmin 12500 IU-ml, 25000 IU-ml injektioneste, liuos SPC 2022-09-07
PL	Resepti	Fragmin 2500 IU-ml injektioneste, liuos SPC 2023-05-08
PL	Resepti	Frekidir 25 mg, 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2023-10-27
PL	Resepti	Frisium 10 mg tabletti SPC 2021-01-04
PL	Resepti	Froidir 25 mg, 100 mg tabletti SPC 2021-02-08
PL	Resepti	Frovaptan 2.5 mg tabletti SPC 2022-03-28
<  Previous 30    |  1  2  3  4  5  6  7  8  |  Next 30   >